High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors [2] (multiple letters)

Cancer

Volumn 101, Issue 3, 2004, Pages 652-

  Sturt, N Julian H ^a   Phillips, Robin K S ^a   Clark, Susan K ^b   Hansmann, Anika ^c   Moeslein, Gabriela ^c   Vogel, Tilman ^c  

^a ST MARK S HOSPITAL   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SULINDAC; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; CANCER PATIENT; DESMOID TUMOR; DRUG MEGADOSE; HUMAN; LETTER; PRIORITY JOURNAL; SOMATIC MUTATION;

EID: 3242806049     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20416     Document Type: Letter

References (0)